AMT-253 in Patients With Advanced Solid Tumours

Clinical trial NCT06209580 · RECRUITING

Trial details

NCT number: NCT06209580
Sponsor: Multitude Therapeutics Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma Advanced Solid Tumors

Start date: 2024-01-31
Primary completion: 2026-04-30
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.